首页 > 市场调查报告书 > 製药

药物开发开发业务受託机关

市场调查报告书

商品编码

1674187

按服务类型、分子类型和地区分類的医药契约製造市场

Contract Pharmaceutical Manufacturing Market, By Service Type, By Molecule Type, By Geography

出版日期: 2025年02月14日 | 出版商:

Coherent Market Insights | 英文 224 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2025 年全球医药契约製造市场规模预计为 2,322.8 亿美元，预计到 2032 年将达到 4,500.7 亿美元，2025 年至 2032 年的复合年增长率为 9.9%。

报告范围		报告详细信息
基准年	2024	2025 年市场规模	2322.8亿美元
效能资料	2020-2024	预测期	2025-2032
预测期：2025 年至 2032 年复合年增长率	9.90％	2032 年金额预测	4507亿美元

数字。医药契约製造市场区域份额（%）（2025 年）

过去几年，全球医药契约製造市场一直稳定成长。製药契约製造是指将某些製药流程（例如药品製造、包装和测试）外包给称为契约製造组织 (CMO) 的第三方公司。降低製造成本和关注核心竞争力的需求日益增加，这是製药公司将其製造需求外包给 CMO 的主要驱动力。此外，由于专利到期导致的持续损失、学名药需求的增加以及药物开发和商业化活动外包的增加，预计将在未来几年进一步推动全球製药契约製造市场的成长。

市场动态

全球医药契约製造市场的成长受到全球心血管疾病盛行率上升和老龄人口成长（心律不整的风险更高）的推动。根据世界卫生组织（WHO）的资料，心血管疾病是全球第一大死因，每年有超过1700万人死于心臟病和中风。此外，专注于小型化和延长电池寿命的技术创新正在扩大心律调节器植入的适应症。然而，心律调节器手术的高成本以及导线缺陷和感染等设备併发症的风险可能会阻碍市场的成长。

研究的主要特点

本报告对全球医药契约製造市场进行了详细分析，并以 2024 年为基准年，展示了预测期（2025-2032 年）的市场规模（十亿美元）和年复合成长率（CAGR%）。
它强调了各个领域的潜在收益成长机会，并说明了该市场的引人注目的投资提案矩阵。
它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
全球医药契约製造市场的主要企业是根据公司亮点、产品系列、关键亮点、财务绩效和策略等参数进行的分析。
主要企业包括龙沙集团 (Lonza Group)、勃林格殷格翰公司 (Boehringer Ingelheim GmbH)、Genpact Limited、埃森哲公司 (Accenture plc)、昆泰跨国公司 (Quintiles Transnational Corporation)、百特 (Baxter)、雷迪博士实验室 (Dr. Reddy's Laborator Inc.工业有限公司 (Teva Pharmaceutical Industries Ltd.)、Piramal Enterprises Ltd.、Covance, Inc.、Catalent, Inc.、Abbvie, Inc. 和 Celltrion。
本报告的见解将使负责人和公司经营团队能够就未来的产品发布、规模扩大、市场扩张和行销策略做出明智的决策。
全球医药契约製造市场迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
相关人员可以透过全球医药契约製造市场分析中使用的各种策略矩阵更轻鬆地做出决策。

公司简介
- Lonza Group
- Boehringer Ingelheim GmbH
- Genpact Limited
- Accenture plc
- Quintiles Transnational Corporation
- Baxter
- Dr. Reddy's Laboratories Ltd.
- Aurobindo Pharma
- Pfizer, Inc.
- The Almac Group
- Teva Pharmaceutical Industries Ltd.
- Piramal Enterprises Ltd.
- Covance, Inc.
- Catalent, Inc.
- Abbvie, Inc.
- Celltrion

第九章分析师建议

兴衰
一致的机会地图

第十章参考文献与调查方法

参考
调查方法

简介目录

Product Code: CMI2397

Global Contract Pharmaceutical Manufacturing Market is estimated to be valued at USD 232.28 Bn in 2025 and is expected to reach USD 450.07 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.9% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 232.28 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	9.90%	2032 Value Projection:	USD 450.07 Bn

Figure. Contract Pharmaceutical Manufacturing Market Share (%), By Region 2025

Contract Pharmaceutical Manufacturing Market - IMG1

The global contract pharmaceutical manufacturing market has been witnessing steady growth over the past few years. Contract pharmaceutical manufacturing refers to the outsourcing of certain pharmaceutical processes such as manufacturing, packaging, and testing of pharmaceutical drugs to a third party company known as contract manufacturing organizations (CMOs). The growing need to reduce manufacturing costs and focus on core competencies are some of the key factors driving pharmaceutical companies to outsource their production requirements to CMOs. In addition, continued patent cliff losses, rising demand for generic drugs, and increasing outsourcing of drug development and commercialization activities are further expected to support the growth of the global contract pharmaceutical manufacturing market in the coming years.

Market Dynamics:

The global contract pharmaceutical manufacturing market growth is driven by rising incidence of cardiovascular diseases and increasing elderly population base globally who are at high risk of arrhythmias. According to the data by World Health Organization, cardiovascular diseases are the leading cause of deaths worldwide with over 17 million lives lost each year due to heart attacks and strokes. Moreover, technological innovations with focus on miniaturization and battery longevity have expanded indications for pacemaker implants. However, high costs associated with pacemaker procedures and risk of device complications such as lead defects and infections can hamper the market growth.

Key Features of the Study:

This report provides an in-depth analysis of the global contract pharmaceutical manufacturing market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global contract pharmaceutical manufacturing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this includes Lonza Group, Boehringer Ingelheim GmbH, Genpact Limited, Accenture plc, Quintiles Transnational Corporation, Baxter , Dr. Reddy's Laboratories Ltd., Aurobindo Pharma, Pfizer, Inc., The Almac Group, Teva Pharmaceutical Industries Ltd., Piramal Enterprises Ltd., Covance, Inc., Catalent, Inc., Abbvie, Inc., and Celltrion.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global contract pharmaceutical manufacturing market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global contract pharmaceutical manufacturing market.

Detailed Segmentation-

By Service Type:
- Contract Manufacturing Organization (CMO)
- API Manufacturing
- Final dosage form manufacturing
- Packaging
- Contract Research Organization (CRO)
- Drug Discovery
- Preclinical Studies
- Early Phase I - IIa
- Phase IIa - III
- Phase IIIb - IV
- Medical Coding and Writing
- Monitoring
- Clinical Data Management
- Others (Protocol Development, etc.)
By Molecule Type:
- Small Molecule
- Large Molecule
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Lonza Group
- Boehringer Ingelheim GmbH
- Genpact Limited
- Accenture plc
- Quintiles Transnational Corporation
- Baxter
- Reddy's Laboratories Ltd.
- Aurobindo Pharma
- Pfizer, Inc.
- The Almac Group
- Teva Pharmaceutical Industries Ltd.
- Piramal Enterprises Ltd.
- Covance, Inc.
- Catalent, Inc.
- Abbvie, Inc.
- Celltrion

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Service Type
- Market Snapshot, By Molecule Type
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Contract Pharmaceutical Manufacturing Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Contract Pharmaceutical Manufacturing Market, By Service Type, 2020 - 2032, (USD Bn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Contract Manufacturing Organization (CMO)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
API Manufacturing
Final dosage form manufacturing
Packaging
Contract Research Organization (CRO)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Drug Discovery
Preclinical Studies
Early Phase I - IIa
Phase IIa - III
Phase IIIb - IV
Medical Coding and Writing
Monitoring
Clinical Data Management
Others (Protocol Development, etc.)

6. Global Contract Pharmaceutical Manufacturing Market, By Molecule Type, 2020 - 2032, (USD Bn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Small Molecule
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Large Molecule
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Contract Pharmaceutical Manufacturing Market, By Region, 2020 - 2032, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2032
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Company Profiles
- Lonza Group
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Boehringer Ingelheim GmbH
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Genpact Limited
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Accenture plc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Quintiles Transnational Corporation
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Baxter
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Dr. Reddy's Laboratories Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Aurobindo Pharma
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Pfizer, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- The Almac Group
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Teva Pharmaceutical Industries Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Piramal Enterprises Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Covance, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Catalent, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Abbvie, Inc.
- Celltrion

9. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

10. References and Research Methodology

References
Research Methodology
About us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/价格

按服务类型、分子类型和地区分類的医药契约製造市场